A detailed history of Vanguard Group Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Vanguard Group Inc holds 11,844,608 shares of NVCR stock, worth $367 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,844,608
Previous 11,127,365 6.45%
Holding current value
$367 Million
Previous $191 Million 2.87%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.61 - $23.34 $11.2 Million - $16.7 Million
717,243 Added 6.45%
11,844,608 $185 Million
Q2 2024

Aug 13, 2024

BUY
$11.83 - $24.05 $13.1 Million - $26.5 Million
1,103,384 Added 11.01%
11,127,365 $191 Million
Q1 2024

May 10, 2024

BUY
$12.42 - $17.29 $3.29 Million - $4.58 Million
264,883 Added 2.71%
10,023,981 $157 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $1.36 Million - $1.93 Million
122,105 Added 1.27%
9,759,098 $146 Million
Q3 2023

Nov 14, 2023

SELL
$16.15 - $42.35 $439,166 - $1.15 Million
-27,193 Reduced 0.28%
9,636,993 $156 Million
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $2.17 Million - $4.44 Million
-53,787 Reduced 0.55%
9,664,186 $401 Million
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $9.63 Million - $20.3 Million
170,637 Added 1.79%
9,717,973 $584 Million
Q4 2022

Feb 10, 2023

BUY
$63.98 - $85.37 $83.7 Million - $112 Million
1,308,501 Added 15.88%
9,547,336 $700 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $8.78 Million - $11.6 Million
129,096 Added 1.59%
8,238,835 $626 Million
Q2 2022

Aug 12, 2022

BUY
$56.6 - $89.9 $6.34 Million - $10.1 Million
112,051 Added 1.4%
8,109,739 $564 Million
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $6.28 Million - $8.82 Million
104,375 Added 1.32%
7,997,688 $663 Million
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $2.36 Million - $3.84 Million
31,453 Added 0.4%
7,893,313 $593 Million
Q3 2021

Nov 12, 2021

BUY
$116.17 - $194.55 $6.13 Million - $10.3 Million
52,737 Added 0.68%
7,861,860 $913 Million
Q2 2021

Aug 13, 2021

BUY
$130.4 - $225.58 $1.02 Billion - $1.76 Billion
7,809,123 New
7,809,123 $1.73 Billion

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.